PSTV - Plus Therapeutics, Inc.

Price Target Consensus

2

Consensus Target

2

High Target

2

Median Target

2

Low Target

Price Target News & Updates

Date Analyst Company Price Target News Title
2025-11-26 Sean Lee H.C. Wainwright $2 H.C. Wainwright Reiterates Buy Rating on Plus Therapeutics Inc. (PSTV)